当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析 - 现金流量表

安科生物

(300009)

  

流通市值:106.29亿  总市值:144.35亿
流通股本:12.30亿   总股本:16.71亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金511,493,367.952,516,919,971.41,942,518,539.311,260,699,934.56
  收到其他与经营活动有关的现金5,657,088.2434,069,524.520,924,369.7318,024,534.83
  经营活动现金流入小计517,150,456.192,550,989,495.91,963,442,909.041,278,724,469.39
  购买商品、接受劳务支付的现金72,636,077.89200,000,902.21253,992,435.56167,714,074.2
  支付给职工以及为职工支付的现金102,873,486.63499,222,102.66396,052,356.08279,157,334.19
  支付的各项税费48,302,502.66236,279,907.58182,425,373.5140,098,177.1
  支付其他与经营活动有关的现金152,507,719.2752,266,112.43575,134,446.28375,330,049.59
  经营活动现金流出小计376,319,786.381,687,769,024.881,407,604,611.42962,299,635.08
  经营活动产生的现金流量净额140,830,669.81863,220,471.02555,838,297.62316,424,834.31
二、投资活动产生的现金流量:
  收回投资收到的现金954,700,0001,150,037,035.43998,815,662.41967,304,820.53
  取得投资收益收到的现金11,499,624.9220,764,621.4814,942,163.6412,040,010.45
  处置固定资产、无形资产和其他长期资产收回的现金净额6,00017,593,923.97441,709.56385,905.68
  处置子公司及其他营业单位收到的现金净额---1,924,052.250
  收到的其他与投资活动有关的现金467,024.453,299,832.993,187,300.962,380,232.05
  投资活动现金流入小计966,672,649.371,191,695,413.871,015,462,784.32982,110,968.71
  购建固定资产、无形资产和其他长期资产支付的现金24,168,266.25126,891,933.5654,382,690.7132,753,045.63
  投资支付的现金1,107,186,0801,516,958,400.481,172,426,545.09768,905,236.21
  支付其他与投资活动有关的现金-845,846.49--
  投资活动现金流出小计1,131,354,346.251,644,696,180.531,226,809,235.8801,658,281.84
  投资活动产生的现金流量净额-164,681,696.88-453,000,766.66-211,346,451.48180,452,686.87
三、筹资活动产生的现金流量:
  吸收投资收到的现金-23,991,248.283,000,000-
  其中:子公司吸收少数股东投资收到的现金--3,000,000-
  取得借款收到的现金-7,000,0007,000,0007,000,000
  收到其他与筹资活动有关的现金--23,991,248.2811,313,750
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-30,991,248.2833,991,248.2818,313,750
  偿还债务支付的现金-5,000,0005,000,0005,000,000
  分配股利、利润或偿付利息支付的现金9,204,420416,774,267.93418,080,540.88418,065,411.16
  其中:子公司支付给少数股东的股利、利润-3,295,7604,680,4604,680,460
  支付其他与筹资活动有关的现金42,474,876.3572,945,601.2363,807,982.7960,355,491.75
  筹资活动现金流出小计51,679,296.35494,719,869.16486,888,523.67483,420,902.91
  筹资活动产生的现金流量净额-51,679,296.35-463,728,620.88-452,897,275.39-465,107,152.91
四、汇率变动对现金及现金等价物的影响-166,960.35-6,894,791.48-3,069,341.75-2,908,775.77
五、现金及现金等价物净增加额-75,697,283.77-60,403,708-111,474,77128,861,592.5
  加:期初现金及现金等价物余额238,201,226.97298,604,934.97298,604,934.97298,604,934.97
  期末现金及现金等价物余额162,503,943.2238,201,226.97187,130,163.97327,466,527.47
补充资料:
  净利润-747,338,705.69-374,553,615.38
  资产减值准备-28,045,640.38-3,099,669.73
  固定资产和投资性房地产折旧-82,806,998.99-39,476,338.06
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-82,806,998.99-39,476,338.06
  无形资产摊销-32,721,735.7-17,147,117.78
  长期待摊费用摊销-2,874,413.64-1,643,528.22
  处置固定资产、无形资产和其他长期资产的损失--6,301,460.04--520,388.61
  固定资产报废损失-383,093.13-133,968.03
  公允价值变动损失--1,881,347.93-986,558.98
  财务费用-1,421,146.95-2,272,731.63
  投资损失--18,254,666.16--11,188,455.65
  递延所得税--20,967,934.27--2,849,632.47
  其中:递延所得税资产减少--19,542,147.14--2,234,525.8
    递延所得税负债增加--1,425,787.13--615,106.67
  存货的减少-14,143,928.99-9,883,159.38
  经营性应收项目的减少--129,395,848.59--295,679,594.77
  经营性应付项目的增加-97,031,592.16-160,568,867.1
  其他-24,843,963.77-11,318,637.72
  现金的期末余额-238,201,226.97-327,466,527.47
  减:现金的期初余额-298,604,934.97-298,604,934.97
  现金及现金等价物的净增加额--60,403,708-28,861,592.5
公告日期2026-04-242026-03-312025-10-282025-08-22
审计意见(境内)标准无保留意见
TOP↑